Pivotal Therapeutics is a publicly traded (CNSX: PVO) specialty pharmaceutical company with a focus on the treatment of cardiovascular diseases. Pivotal’s innovative and proprietary lead product, VASCAZENTM, is a prescription grade, ultra-pure Omega-3 for the dietary management of cardiovascular disease in patients manifesting an Omega-3 deficiency.
